InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
58,459.53
(
3.20%
)
Post# of 426487
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ziploc_1

Send PM Follow Ignore
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

ziploc_1

Re: Meowza post# 381052

Wednesday, 06/22/2022 4:59:35 PM

Wednesday, June 22, 2022 4:59:35 PM

Post# of 426487
M... the only way to validate that would be with a CVOT trial"

The efficacy of Vascepa correlates with the quantity of pure unoxidized EPA in the Vascepa patented gelatin capsule...

Because the EPA in the inferior capsule of gV is being oxidized over time...and is less in amount, when used by the patient, than is the EPA in the oxidation-resistant capsule of Vascepa, then the patient is not getting what he is paying for...and his health may be suffering as a result.

gV has been approved by the FDA as a 'biosimilar" to Vascepa but has never been submitted a CVOT trial...and gV may not be truly biosimilar to Vascepa because gVs are employing a less protective and effective capsule for their EPA.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!